Treatment adherence
Join2move usage drop-off
Open access · cc by · source: Europe PMC
Patients with knee/hip OA used Join2move less than intended: 94% started, 46% hit 6/9 modules, only 19% finished all nine.
Study at a glance
- Design
- Other — Secondary analysis of the intervention arm of a 199-person RCT; control arm unused (usage logs + predictors)
- N
- N=100 · Intervention-arm users given login credentials
- Population
- Adults with knee and/or hip osteoarthritis assigned to Join2move
- Outcome
- Module completion and predictors of program adherence
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
Module completion fell from 80% (module 1) to 55% (module 2); older age and comorbidity predicted lower completion (OR 0.33 for comorbidity).
Methodology
Mixed-methods analysis of usage logs plus predictors for a web-based PA intervention (Join2move) among knee/hip osteoarthritis patients.
Limitations
Does not test clinical OA outcomes of high vs low usage in an RCT contrast here.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Multiple studies in this library examine treatment adherence with empirical patient or population outcomes rather than opinion alone.
Evidence for the claim as stated.
Module completion fell from 80% (module 1) to 55% (module 2); older age and comorbidity predicted lower completion (OR 0.33 for comorbidity).
Evidence for the claim as stated.
Effect sizes and settings differ across treatment adherence studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Effect sizes and settings differ across treatment adherence studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
- Supports · Does wireless BP monitoring boost patient activation’s benefits?
- Supports · ALICE pillbox app RCT
Related papers in this topic
Same topic cluster — not a recommendation engine.